No Data
No Data
Analyst Estimates: Here's What Brokers Think Of LifeMD, Inc. (NASDAQ:LFMD) After Its Second-Quarter Report
Express News | Cantor Fitzgerald Reiterates Overweight on LifeMD, Maintains $15 Price Target
LifeMD Analyst Ratings
LifeMD, Inc. (LFMD) Q2 2024 Earnings Call Transcript
B. Riley Trims Price Target on LifeMD to $11 From $12, Maintains Buy Rating
Strong Growth and Positive Outlook Justify Buy Rating for LifeMD
No Data